Tarsus Pharmaceuticals (TARS) Short Interest Ratio & Short Volume → Shocking: One AI startup's revenue could surge 4,735% (From Manward Press) (Ad) Free TARS Stock Alerts $38.24 -0.34 (-0.88%) (As of 05/17/2024 08:54 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Tarsus Pharmaceuticals Short Interest DataCurrent Short Volume7,660,000 sharesPrevious Short Volume7,900,000 sharesChange Vs. Previous Month-3.04%Dollar Volume Sold Short$240.75 millionShort Interest Ratio / Days to Cover10.7Last Record DateApril 30, 2024Outstanding Shares37,780,000 sharesPercentage of Shares Shorted20.28%Today's Trading Volume586,900 sharesAverage Trading Volume712,985 sharesToday's Volume Vs. Average82% Short Selling Tarsus Pharmaceuticals ? Sign up to receive the latest short interest report for Tarsus Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatTARS Short Interest Over TimeTARS Days to Cover Over TimeTARS Percentage of Float Shorted Over Time Ad True Market Insiders4 Cryptos BETTER than BitcoinFormer Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than BitcoinClick For My #1 FREE Crypto for 2024 Tarsus Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20247,660,000 shares $240.75 million -3.0%N/A10.7 $31.43 4/15/20247,900,000 shares $276.03 million +0.6%N/A10.7 $34.94 3/31/20247,850,000 shares $285.35 million +9.0%N/A10.1 $36.35 3/15/20247,200,000 shares $227.38 million +19.4%N/A9.3 $31.58 2/29/20246,030,000 shares $230.47 million +6.5%N/A7.5 $38.22 2/15/20245,660,000 shares $178.57 million +4.2%N/A7.7 $31.55 Get the Latest News and Ratings for TARS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Tarsus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/31/20245,430,000 shares $147.91 million +8.2%N/A7.7 $27.24 1/15/20245,020,000 shares $110.94 million +0.4%N/A7.9 $22.10 12/31/20235,000,000 shares $101.25 million +1.8%N/A8.2 $20.25 12/15/20234,910,000 shares $93.54 million +10.3%N/A8.3 $19.05 11/30/20234,450,000 shares $73.56 million -0.2%N/A8.1 $16.53 11/15/20234,460,000 shares $79.97 million +6.2%N/A9.2 $17.93 10/31/20234,200,000 shares $59.81 million +5.0%N/A10.1 $14.24 10/15/20234,000,000 shares $51.92 million -19.4%N/A7.6 $12.98 9/30/20234,960,000 shares $88.14 million +13.0%N/A10.2 $17.77 9/15/20234,390,000 shares $70.85 million -2.7%N/A10.1 $16.14 8/31/20234,510,000 shares $78.97 million +0.7%N/A10.8 $17.51 8/15/20234,480,000 shares $76.16 million +17.9%N/A11.3 $17.00 7/31/20233,800,000 shares $83.64 million +65.9%N/A9.9 $22.01 7/15/20232,290,000 shares $40.42 million +2.2%13.0%10.7 $17.65 6/30/20232,240,000 shares $40.48 million +42.7%11.4%11 $18.07 6/15/20231,570,000 shares $29.23 million +72.6%8.0%7.8 $18.62 5/31/2023909,800 shares $15.24 million +6.8%4.7%5.5 $16.75 5/15/2023852,000 shares $14.11 million -11.3%4.4%6.2 $16.56 4/30/2023960,800 shares $14.34 million +0.2%5.0%8.7 $14.92 4/15/2023959,400 shares $11.10 million -3.3%5.0%9.3 $11.57 3/31/2023991,600 shares $12.46 million -4.7%5.2%12 $12.57 3/15/20231,040,000 shares $14.29 million +4.3%5.4%14.2 $13.74 2/28/2023996,700 shares $15.44 million +1.1%5.4%12 $15.49 2/15/2023985,900 shares $15.12 million +1.8%5.3%11.2 $15.34 1/31/2023968,800 shares $15.27 million -6.9%5.1%9.9 $15.76 1/15/20231,040,000 shares $15.12 million No Change5.5%9.7 $14.54 12/30/20221,040,000 shares $15.25 million +19.0%6.1%10.9 $14.66 12/15/2022874,300 shares $12.91 million -28.9%5.1%9.1 $14.77 11/30/20221,230,000 shares $20.68 million -3.2%7.2%12.8 $16.81 11/15/20221,270,000 shares $22.61 million -14.8%7.4%13.7 $17.80 10/31/20221,490,000 shares $27.45 million -0.7%8.9%16.6 $18.42 10/15/20221,500,000 shares $25.47 million +0.7%9.0%17.5 $16.98 9/30/20221,490,000 shares $25.51 million +19.2%8.9%17.4 $17.12 9/15/20221,250,000 shares $19.96 million No Change7.5%11.1 $15.97Global crypto currency reset (41 major banks signed up) (Ad)Behind closed doors, at least 41 major US banks have signed up to a strange new crypto project... Here's everything you need to know. TARS Short Interest - Frequently Asked Questions What is Tarsus Pharmaceuticals' current short interest? Short interest is the volume of Tarsus Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 7,660,000 shares of TARS short. Learn More on Tarsus Pharmaceuticals' current short interest. What is a good short interest ratio for Tarsus Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TARS shares currently have a short interest ratio of 11.0. Learn More on Tarsus Pharmaceuticals's short interest ratio. Which institutional investors are shorting Tarsus Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Tarsus Pharmaceuticals: StemPoint Capital LP. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Tarsus Pharmaceuticals' short interest increasing or decreasing? Tarsus Pharmaceuticals saw a decline in short interest during the month of April. As of April 30th, there was short interest totaling 7,660,000 shares, a decline of 3.0% from the previous total of 7,900,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Tarsus Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to Tarsus Pharmaceuticals: Vir Biotechnology, Inc. (6.63%), Neumora Therapeutics, Inc. (12.27%), 4D Molecular Therapeutics, Inc. (18.61%), Cullinan Oncology, Inc. (10.23%), Scholar Rock Holding Co. (16.78%), BioCryst Pharmaceuticals, Inc. (16.30%), Inhibrx, Inc. (4.18%), Autolus Therapeutics plc (1.32%), Fusion Pharmaceuticals Inc. (4.64%), Ginkgo Bioworks Holdings, Inc. (20.84%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Tarsus Pharmaceuticals stock? Short selling TARS is an investing strategy that aims to generate trading profit from Tarsus Pharmaceuticals as its price is falling. TARS shares are trading down $0.34 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Tarsus Pharmaceuticals? A short squeeze for Tarsus Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of TARS, which in turn drives the price of the stock up even further. How often is Tarsus Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TARS, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Vir Biotechnology Short Interest Neumora Therapeutics Short Interest 4D Molecular Therapeutics Short Interest Cullinan Oncology Short Interest Scholar Rock Short Interest BioCryst Pharmaceuticals Short Interest Inhibrx Short Interest Autolus Therapeutics Short Interest Fusion Pharmaceuticals Short Interest Ginkgo Bioworks Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:TARS) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersShocking: One AI startup's revenue could surge 4,735%Manward PressThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaNext President (Not Trump. Not Biden.)The Freeport SocietyUrgent Nvidia WarningAltimetryElon’s New Device is About to Shock the WorldInvestorPlace"The Biggest Drug Ever" Is ComingBehind the MarketsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders